TimesSquare Capital Management’s Amedisys AMED Stock Holding History

TimesSquare Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-289,128	Closed	-$33.9M	–	218
2018 Q4	$33.9M	Sell	289,128 -74,572	-21%	-$8.79M	0.29%	137
2018 Q3	$45.4M	Buy	363,700 +34,735	+11%	+$3.84M	0.3%	131
2018 Q2	$28.1M	Sell	328,965 -120,330	-27%	-$8.84M	0.19%	177
2018 Q1	$27.1M	Sell	449,295 -32,400	-7%	-$1.85M	0.18%	178
2017 Q4	$25.4M	Sell	481,695 -138,470	-22%	-$7.3M	0.17%	184
2017 Q3	$34.7M	Sell	620,165 -111,505	-15%	-$5.9M	0.23%	163
2017 Q2	$46M	Buy	731,670 +99,380	+16%	+$5.79M	0.3%	131
2017 Q1	$32.3M	Sell	632,290 -18,000	-3%	-$858K	0.21%	179
2016 Q4	$27.7M	Buy	650,290 +242,220	+59%	+$10.3M	0.19%	188
2016 Q3	$19.4M	Buy	+408,070	New	+$20.4M	0.13%	210

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TimesSquare Capital Management's AMED Position: Q1 2019 in Review

TimesSquare Capital Management sold out of Amedisys (AMED) in Q1 2019, closing a stake of 289,128 shares — an estimated $33.9M sold.

TimesSquare Capital Management first reported a position in AMED in Q3 2016 and held it in 10 quarters. The position peaked at $46M in Q2 2017. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

TimesSquare Capital Management reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
TimesSquare Capital Management sold 289,128 Amedisys shares in Q1 2019, an estimated $33.9M.
TimesSquare Capital Management first reported a position in Amedisys in Q3 2016 and held it in 10 quarters.
TimesSquare Capital Management's Amedisys position peaked at $46M in Q2 2017.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on TimesSquare Capital Management's 13F filing for Q1 2019, filed 10 May 2019.